IU Med School To Study HIV In Scott County

The Indiana University School of Medicine received a grant Monday to study HIV patients’ access to testing and treatment in Austin, Indiana, where an outbreak of HIV cases occurred this year.

The two-year, $200,000 grant from the National Institute on Drug Abuse will be supplemented by funding from the IU School of Medicine.

Partnering with the British Columbia Centre for Excellence in HIV/AIDS, IU School of Medicine will implement a program called Treatment as Prevention¨, a program developed by BC-CfE.

“The current outbreak in this rural setting in Indiana is a potential canary in the coal mine, if you will,” says Diane Janowicz, Assistant Professor of Clinical Medicine in IU School of Medicine, Division of Infectious Diseases. “Such an outbreak may occur again given the epidemic of injection drug use that we’re seeing across our country.”

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below